Clinical trial

Effect of Liraglutide on Pulsatile Insulin Secretion in Subjects With Type 2 Diabetes

NCT01507311

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1999-09-01

PhasePHASE1

Study timeline

Study start (unknown)1999-09-01Date precision: month

Registry last updated2017-01-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetesunresolved

Diabetes Mellitus, Type 2unresolved

Interventions

liraglutideDRUG · verified · RxNorm: liraglutide

placeboDRUG

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01507311 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.